1776 Wealth’s Gilead Sciences GILD Stock Holding History

1776 Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200	Closed	-$15K	–	191
2020 Q2	$15K	Sell	200 -500	-71%	-$38.3K	0.01%	267
2020 Q1	$46K	Buy	700 +200	+40%	+$13.8K	0.02%	226
2019 Q4	$32K	Buy	+500	New	+$32.6K	0.03%	213

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

1776 Wealth's GILD Position: Q3 2020 in Review

1776 Wealth sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 200 shares — an estimated $15K sold.

1776 Wealth first reported a position in GILD in Q4 2019 and held it in 3 quarters. The position peaked at $46K in Q1 2020. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

1776 Wealth reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
1776 Wealth sold 200 Gilead Sciences shares in Q3 2020, an estimated $15K.
1776 Wealth first reported a position in Gilead Sciences in Q4 2019 and held it in 3 quarters.
1776 Wealth's Gilead Sciences position peaked at $46K in Q1 2020.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on 1776 Wealth's 13F filing for Q3 2020, filed 12 Nov 2020.